It’s called ‘Right to Try,’ and the idea is to give access to untested and unapproved drugs to people with terminal diseases. The bill was signed on Wednesday by President Trump, but internationally recognized cancer researcher Dr. Anthony Tolcher, the founder and CEO of San Antonio’s Next Oncology, says its a bad idea and the wrong way to go about getting treatments to patients, News Radio 1200 WOAI reports.
“First and foremost, it is ‘do no harm’,” Tolcher said. “That is one of the gold standard principles that we live by in medicine. But even with drugs that might seem to be perfectly sound, it could lead to side effects.”